PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Jan-2026 OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate Businesswire
06-Jan-2026 Newleos Therapeutics Announces Dosing of First Participant in SOAR Phase 2 Study of NTX-1472 for Social Anxiety Disorder Businesswire
06-Jan-2026 Lysoway Therapeutics Announces Phase I Readiness of Brain-Penetrant TRPML1 Agonist LW-1017 and Nomination of a TMEM175 Development Candidate Businesswire
06-Jan-2026 Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360 Businesswire
06-Jan-2026 Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines Businesswire
06-Jan-2026 HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma HUTCHMED
06-Jan-2026 Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma Johnson & Johnson
06-Jan-2026 Research award will accelerate research to map brain electrical circuits University of Nottingham
06-Jan-2026 ALST Signs Non-Disclosure Agreement with Major Toronto University for Proposed Allstar Sports Centre Development ACCESS Newswire
06-Jan-2026 LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington’s Disease LoQus23 Therapeutics
06-Jan-2026 HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma HUTCHMED
06-Jan-2026 Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging Biotium
06-Jan-2026 Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation Acesion Pharma
06-Jan-2026 Ikarovec to Advance Pipeline With Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology Businesswire
06-Jan-2026 MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy* GSK
06-Jan-2026 Companion Diagnostics Market Research Report 2026 | Analysis, Size, Share and Forecast to 2031 Medi-Tech Insights
06-Jan-2026 Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium Businesswire
06-Jan-2026 Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is expected to extend asset exclusivity in EU into 2044 Newron
06-Jan-2026 Iksuda to present preliminary analysis of oesophageal cancer data from Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium Iksuda
06-Jan-2026 Medical Care Technologies Inc. (OTC Pink:MDCE) Announces Attendance at CES 2026 in Las Vegas ACCESS Newswire